Amphotericin B and Itraconazole: Clinical Management, Indications, Side Effects

Uniqcret doctor knowledgesINMEDINMED IDINMED KUB
On this page

Amphotericin B

Indications:

Amphotericin B is a broad-spectrum antifungal used for the treatment of severe, life-threatening systemic fungal infections, such as:

  • Cryptococcal meningitis (especially in immunocompromised patients, like those with HIV/AIDS)
  • Invasive aspergillosis
  • Candidiasis (especially invasive candidiasis)
  • Mucormycosis
  • Histoplasmosis
  • Coccidioidomycosis

It is typically reserved for serious fungal infections because of its significant toxicity profile.

Drug Management & Administration:

  • Conventional Amphotericin B (Deoxycholate):
    • Dose: 0.5–1.5 mg/kg/day IV over 2–6 hours.
    • Requires close monitoring due to high risk of nephrotoxicity.
  • Lipid-based formulations (Liposomal Amphotericin B, Amphotericin B lipid complex):
    • Dose: 3–5 mg/kg/day IV.
    • Liposomal formulations are preferred in patients at high risk for renal toxicity as they are less nephrotoxic.
  • Pre-medication: Administer antipyretics (e.g., acetaminophen), antihistamines, and sometimes corticosteroids to prevent infusion-related reactions such as fever, chills, and rigors.

Side Effects:

  1. Nephrotoxicity (Acute Kidney Injury - AKI):
    • Most common and serious side effect.
    • Mechanism: Direct tubular damage and afferent arteriole vasoconstriction leading to reduced renal blood flow.
    • Management: Adequate hydration with normal saline before and after administration, regular monitoring of serum creatinine, and switching to liposomal formulations if necessary.
  2. Type 1 Renal Tubular Acidosis (RTA):
    • Results in hypokalemia and hypomagnesemia.
    • Management: Monitor and replace potassium and magnesium as needed.
  3. Electrolyte Imbalance:
    • Hypokalemia and hypomagnesemia.
    • Regular monitoring and supplementation are required.
  4. Infusion-related reactions:
    • Fever, chills, rigors.
    • Management: Pre-medication with acetaminophen and antihistamines; use of liposomal formulations reduces these reactions.
  5. Anemia:
    • Amphotericin B suppresses erythropoiesis, leading to normocytic, normochromic anemia with prolonged use.
  6. Hepatotoxicity (rare).

Itraconazole

Indications:

Itraconazole is an oral triazole antifungal that is used for:

  • Blastomycosis
  • Histoplasmosis
  • Sporotrichosis
  • Aspergillosis (especially in chronic or allergic forms)
  • Onychomycosis (fungal nail infections)

Itraconazole is preferred for less severe or chronic infections compared to Amphotericin B.

Drug Management & Administration:

  • Oral Capsules:
    • Dose: 200 mg once or twice daily depending on the infection.
    • For onychomycosis, 200 mg daily for 12 weeks is commonly used.
  • Oral Solution:
    • Better absorption when taken on an empty stomach.
    • Dose: 200 mg twice daily for systemic infections like aspergillosis.
  • Food Interactions: Capsules should be taken with food for better absorption, whereas the oral solution should be taken on an empty stomach.

Side Effects:

  1. Hepatotoxicity:
    • Elevations in liver enzymes are common.
    • Monitoring: Routine liver function tests (LFTs) are recommended, especially with long-term therapy.
  2. Cardiotoxicity:
    • Can lead to heart failure or worsening of existing heart failure.
    • Contraindicated in patients with congestive heart failure.
  3. Drug interactions:
    • Potent CYP3A4 inhibitor, leading to significant interactions with drugs metabolized by this enzyme (e.g., statins, anticoagulants).
    • Careful review of all patient medications is essential to avoid interactions.
  4. GI side effects: Nausea, vomiting, diarrhea.
  5. Headache and dizziness: Common, but typically mild.

Management and Monitoring

For both drugs, appropriate management involves:

  • Amphotericin B: Close monitoring of renal function, electrolytes (especially potassium and magnesium), and for any infusion-related reactions. Use lipid-based formulations when possible to reduce nephrotoxicity.
  • Itraconazole: Monitor liver function regularly, check for signs of heart failure, and review potential drug interactions due to CYP3A4 inhibition.

Prescription Examples:

Amphotericin B (Liposomal formulation)

  • Dose: 3 mg/kg/day IV.
  • Route: IV infusion over 2–6 hours.
  • Pre-medications: Acetaminophen 500 mg PO and diphenhydramine 50 mg IV 30 minutes before infusion.
  • Monitoring: Serum creatinine, electrolytes (potassium and magnesium), daily urine output, and regular complete blood counts for anemia.
  • Hydration: 500–1000 mL of normal saline before infusion to prevent nephrotoxicity.

Itraconazole

  • Dose: 200 mg PO twice daily (for systemic fungal infections).
  • Route: Oral.
  • Administration: Take capsules with food, or the oral solution on an empty stomach.
  • Monitoring: Liver function tests every 1–2 weeks initially, then monthly if long-term therapy is planned. Monitor for signs of heart failure, especially in high-risk patients.

Summary of Management Approach:

Amphotericin B:

  • Indications: Severe systemic fungal infections (cryptococcal meningitis, invasive aspergillosis).
  • Administration: IV, 0.5–1.5 mg/kg/day (conventional) or 3–5 mg/kg/day (liposomal).
  • Side Effects: AKI, electrolyte imbalances, infusion reactions, anemia.
  • Monitoring: Renal function, electrolytes, pre-medication to prevent infusion reactions.

Itraconazole:

  • Indications: Less severe fungal infections (blastomycosis, histoplasmosis, onychomycosis).
  • Administration: Oral, 200 mg once or twice daily.
  • Side Effects: Hepatotoxicity, cardiotoxicity, drug interactions.
  • Monitoring: Liver function, heart function, and potential drug interactions.
0
Message for International and Thai ReadersUnderstanding My Medical Context in ThailandRead more →Message for International and Thai ReadersUnderstanding My Broader Content Beyond MedicineRead more →

Comments

No comments yet. Be the first to share your thoughts.

Sign in to comment